WINDSOR HOUSE GROUP PRACTICE — All Prescriptions & Medications — Page 10
Practice Code: B86057 | LEEDS, LS27 9NB
Showing results 451-500 of 751
| Medication | Items (12m) ↓ | Quantity | Cost | vs National |
|---|---|---|---|---|
| Liquid OTC glucose for diabetic hypo treatment (0913541) | 42 | 26.5K | £413 | +83.3% ▲ |
| Dexamethasone | 42 | 1,340 | £610 | -29.7% ▼ |
| 42 | 824 | £1.1K | +283.6% ▲ | |
| 42 | 3,970 | £695 | +53.8% ▲ | |
| 42 | 2,440 | £8.4K | +72.4% ▲ | |
| Prucalopride | 41 | 1,512 | £936 | +5.3% ▲ |
| Diclofenac sodium | 41 | 2,391 | £282 | -19.2% ▼ |
| Ciprofloxain/dexameth | 41 | 205 | £239 | +33.5% ▲ |
| Ketoconazole | 41 | 1,710 | £230 | +312.1% ▲ |
| Midazolam hydrochloride | 41 | 372 | £204 | +0.2% vs avg |
| Hydralazine hydrochloride | 40 | 3,360 | £179 | -5.2% ▼ |
| Chlorpromazine hydrochloride | 40 | 2,184 | £1.7K | +1.7% vs avg |
| Ibandronic acid | 40 | 1,512 | £1.4K | +10.1% ▲ |
| 40 | 144 | £955 | +358.0% ▲ | |
| Telmisartan | 39 | 1,227 | £231 | -32.7% ▼ |
| Fosfomycin trometamol | 39 | 71 | £328 | +37.0% ▲ |
| Hydroxycarbamide | 39 | 3,668 | £577 | +35.2% ▲ |
| Travoprost | 39 | 195 | £298 | -17.2% ▼ |
| 39 | 1,390 | £3.4K | +90.2% ▲ | |
| Amiloride hydrochloride | 38 | 1,764 | £876 | +51.0% ▲ |
| Tibolone | 38 | 3,416 | £316 | +24.2% ▲ |
| Riboflavin | 38 | 6,104 | £8.4K | +311.0% ▲ |
| Azelaic acid | 38 | 1,170 | £252 | +59.0% ▲ |
| 38 | 735 | £822 | +46.7% ▲ | |
| 38 | 325 | £93 | +31.2% ▲ | |
| 38 | 540 | £1.8K | +23.7% ▲ | |
| Insulin detemir | 37 | 212 | £1.8K | -52.8% ▼ |
| 37 | 1,018 | £204 | +170.8% ▲ | |
| Cinnarizine | 36 | 3,445 | £156 | -23.1% ▼ |
| Other health supplement preparations | 36 | 6,426 | £184 | -24.2% ▼ |
| Acetic acid | 36 | 180 | £169 | +210.8% ▲ |
| 36 | 1,650 | £4.1K | +136.3% ▲ | |
| Clomipramine hydrochloride | 35 | 2,072 | £397 | -17.0% ▼ |
| Zinc sulfate monohydrate | 35 | 1,470 | £279 | +295.1% ▲ |
| Salicylic acid | 35 | 389 | £107 | +176.8% ▲ |
| 35 | 570 | £1.5K | +197.6% ▲ | |
| 35 | 320 | £811 | +44.8% ▲ | |
| 35 | 3,470 | £209 | -14.5% ▼ | |
| Nizatidine | 34 | 2,130 | £2.3K | -1.2% vs avg |
| Sodium feredetate | 34 | 16.4K | £451 | +18.7% ▲ |
| Erythromycin | 34 | 1,650 | £722 | +150.4% ▲ |
| Amorolfine hydrochloride | 34 | 230 | £296 | +47.3% ▲ |
| 34 | 29.6K | £1.6K | -10.8% ▼ | |
| Levomepromazine hydrochloride | 33 | 306 | £586 | +43.3% ▲ |
| Analgesics with anti-emetics | 33 | 876 | £302 | +133.2% ▲ |
| Diclofenac sodium | 33 | 1,650 | £1.2K | +37.7% ▲ |
| Olmesartan medoxomil | 32 | 1,400 | £60 | -53.6% ▼ |
| Imipramine hydrochloride | 32 | 1,641 | £59 | +25.5% ▲ |
| Ipratropium bromide | 32 | 38 | £265 | +97.3% ▲ |
| 32 | 1,120 | £1.3K | -13.8% ▼ |
Data sourced from NHSBSA English Prescribing Dataset, CQC, and GP Patient Survey. Prescribing data does not indicate quality of care. Higher prescribing rates may reflect patient demographics. Always consult your GP for medical advice.